Kala Pharmaceuticals (EYSUVIS and INVELTYS) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Kala Pharmaceuticals (EYSUVIS and INVELTYS) General Information
Description
Portfolio of dry eye disease treatments and drugs intended to simplify ocular surgery. The drugs act as a corticosteroid for the treatment of post-operative inflammation and pain following ocular surgery which further enhance penetration of loteprednol etabonate (LE) into target tissues of the eye.
Contact Information
Website
www.eysuvis.comCorporate Office
- 1167 Massachusetts Avenue
- Arlington, MA 02476
- United States
Corporate Office
- 1167 Massachusetts Avenue
- Arlington, MA 02476
- United States
Kala Pharmaceuticals (EYSUVIS and INVELTYS) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kala Pharmaceuticals (EYSUVIS and INVELTYS) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kala Pharmaceuticals (EYSUVIS and INVELTYS) FAQs
-
Where is Kala Pharmaceuticals (EYSUVIS and INVELTYS) headquartered?
Kala Pharmaceuticals (EYSUVIS and INVELTYS) is headquartered in Arlington, MA.
-
What industry is Kala Pharmaceuticals (EYSUVIS and INVELTYS) in?
Kala Pharmaceuticals (EYSUVIS and INVELTYS)’s primary industry is Pharmaceuticals.
-
Is Kala Pharmaceuticals (EYSUVIS and INVELTYS) a private or public company?
Kala Pharmaceuticals (EYSUVIS and INVELTYS) is a Private company.
-
What is the current valuation of Kala Pharmaceuticals (EYSUVIS and INVELTYS)?
The current valuation of Kala Pharmaceuticals (EYSUVIS and INVELTYS) is .
-
What is Kala Pharmaceuticals (EYSUVIS and INVELTYS)’s current revenue?
The current revenue for Kala Pharmaceuticals (EYSUVIS and INVELTYS) is .
-
Who are Kala Pharmaceuticals (EYSUVIS and INVELTYS)’s investors?
Kala Bio has invested in Kala Pharmaceuticals (EYSUVIS and INVELTYS).
-
When was Kala Pharmaceuticals (EYSUVIS and INVELTYS) acquired?
Kala Pharmaceuticals (EYSUVIS and INVELTYS) was acquired on 08-Jul-2022.
-
Who acquired Kala Pharmaceuticals (EYSUVIS and INVELTYS)?
Kala Pharmaceuticals (EYSUVIS and INVELTYS) was acquired by Alcon.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process